Rare disease drug development provides unique issues and challenges. Key among them is the smallness of the patient population, which complicates study design, study sizing and powering, study conduct, the handling of missing data, statistical analysis, and interpretability of study results.
Our rare disease data science team can help before your study starts, during your study, and after your study ends. Contract with us per hour, per deliverable, per dedicated time fixed rate. You’ll love our pricing.
